Goals and Objectives:
- Developing novel drugs based on patient’s omics and biomarker data for Precision Cancer Medicine
- Discovering new treatments for rare cancers and neurodegenerative diseases by repurposing approved medications
- Developing novel liposomal based drug delivery formulations to improve therapeutic index of both experimental and clinically approved drugs
- Applying preclinical-ADME drug design strategies for creating drug-like small molecules for preclinical IND enabling studies
